Concepedia

Lucely Cetina

LC

37

Publications

1.8K

Citations

24

H-Index

2002

Active since

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Clinical Research Management

Universidad de Cuautitlán Izcalli

Lucely Cetina is an author at Instituto Nacional de Cancerología specializing in medicine, oncology, and cervical cancer.

ORCID

Top concepts

Publications per year

2002–2021

37

Publications

37

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

Myrna Candelaria, Dolores Gallardo‐Rincón, Claudia Arce et al. · Annals of Oncology · 2007 · 249 citations

, , +7

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Pilar Zambrano, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas et al. · BMC Cancer · 2005 · 150 citations · Full text

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

Jaime Coronel, Lucely Cetina, Irlanda Pacheco et al. · Medical Oncology · 2010 · 131 citations

, , +10

Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study

Alma Chávez‐Blanco, Blanca Segura-Pacheco, Enrique Pérez‐Cárdenas et al. · Molecular Cancer · 2005 · 127 citations · Full text

Radiosensitizers in cervical cancer. Cisplatin and beyond

Myrna Candelaria, Alicia Garcia-Arias, Lucely Cetina et al. · Radiation Oncology · 2006 · 107 citations · Full text

, , +9

Rows per page

1–5 of 37